Leishmania virulence factors: Focus on the metalloprotease GP63

Microbes and Infection

Volumn 14, Issue 15, 2012, Pages 1377-1389

  Olivier, Martin ^a   Atayde, Vanessa Diniz ^a   Isnard, Amandine ^a   Hassani, Kasra ^a   Shio, Marina Tiemi ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

GP63; Host pathogen interaction; Innate immunity; Leishmania; Macrophage; Signalling

Indexed keywords

ACID PHOSPHATASE; AP 1 PROTEIN; CYSTEINE PROTEINASE; GIPL PROTEIN; GP63 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPHOSPHOGLYCAN; LPG PROTEIN; MARCKS PROTEIN; METALLOPROTEINASE; PHOSPHOLIPID DERIVATIVE; PPG PROTEIN; PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CELL SURVIVAL; ENZYME RELEASE; EXOSOME; LEISHMANIA; LEISHMANIASIS; LIFE CYCLE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SIGNAL TRANSDUCTION;

ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; LEISHMANIA; LEISHMANIASIS; METALLOENDOPEPTIDASES; PSYCHODIDAE; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

EID: 84870826735     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.05.014     Document Type: Article

References (83)

1. Olivier M., Gregory D.J., Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 2005, 18:293-305.
2. Shio M.T., Hassani K., Isnard A., Ralph B., Contreras I., Gomez M.A., Abu-Dayyeh I., Olivier M. Host cell signalling and Leishmania mechanisms of evasion. J. Trop. Med. 2012, 2012:819512.
3. Chang K.P., McGwire B.S. Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol. Dis. 2002, 1:1.
4. Chaudhuri G., Chaudhuri M., Pan A., Chang K.P. Surface acid proteinase (GP63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J. Biol. Chem. 1989, 264:7483-7489.
5. Peacock C.S., Seeger K., Harris D., Murphy L., Ruiz J.C., Quail M.A., Peters N., Adlem E., Tivey A., Aslett M., Kerhornou A., Ivens A., Fraser A., Rajandream M.A., Carver T., Norbertczak H., Chillingworth T., Hance Z., Jagels K., Moule S., Ormond D., Rutter S., Squares R., Whitehead S., Rabbinowitsch E., Arrowsmith C., White B., Thurston S., Bringaud F., Baldauf S.L., Faulconbridge A., Jeffares D., Depledge D.P., Oyola S.O., Hilley J.D., Brito L.O., Tosi L.R., Barrell B., Cruz A.K., Mottram J.C., Smith D.F., Berriman M. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat. Genet. 2007, 39:839-847.
6. Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., Sisk E., Rajandream M.A., Adlem E., Aert R., Anupama A., Apostolou Z., Attipoe P., Bason N., Bauser C., Beck A., Beverley S.M., Bianchettin G., Borzym K., Bothe G., Bruschi C.V., Collins M., Cadag E., Ciarloni L., Clayton C., Coulson R.M., Cronin A., Cruz A.K., Davies R.M., De Gaudenzi J., Dobson D.E., Duesterhoeft A., Fazelina G., Fosker N., Frasch A.C., Fraser A., Fuchs M., Gabel C., Goble A., Goffeau A., Harris D., Hertz-Fowler C., Hilbert H., Horn D., Huang Y., Klages S., Knights A., Kube M., Larke N., Litvin L., Lord A., Louie T., Marra M., Masuy D., Matthews K., Michaeli S., Mottram J.C., Muller-Auer S., Munden H., Nelson S., Norbertczak H., Oliver K., O'Neil S., Pentony M., Pohl T.M., Price C., Purnelle B., Quail M.A., Rabbinowitsch E., Reinhardt R., Rieger M., Rinta J., Robben J., Robertson L., Ruiz J.C., Rutter S., Saunders D., Schafer M., Schein J., Schwartz D.C., Seeger K., Seyler A., Sharp S., Shin H., Sivam D., Squares R., Squares S., Tosato V., Vogt C., Volckaert G., Wambutt R., Warren T., Wedler H., Woodward J., Zhou S., Zimmermann W., Smith D.F., Blackwell J.M., Stuart K.D., Barrell B., Myler P.J. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
7. Lodge R., Descoteaux A. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania. Clin. Immunol. 2005, 114:256-265.
8. Descoteaux A., Matlashewski G. C-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 1989, 9:5223-5227.
9. Descoteaux A., Turco S.J. Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta 1999, 1455:341-352.
10. Delgado-Dominguez J., Gonzalez-Aguilar H., Aguirre-Garcia M., Gutierrez-Kobeh L., Berzunza-Cruz M., Ruiz-Remigio A., Robles-Flores M., Becker I. Leishmania mexicana lipophosphoglycan differentially regulates PKCalpha-induced oxidative burst in macrophages of BALB/c and C57Bl/6 mice. Parasite Immunol. 2010, 32:440-449.
11. Coelho-Finamore J.M., Freitas V.C., Assis R.R., Melo M.N., Novozhilova N., Secundino N.F., Pimenta P.F., Turco S.J., Soares R.P. Leishmania infantum: lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. Int. J. Parasitol. 2011, 41:333-342.
12. Spath G.F., Epstein L., Leader B., Singer S.M., Avila H.A., Turco S.J., Beverley S.M. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:9258-9263.
13. Desjardins M., Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 1997, 185:2061-2068.
14. Beverley S.M., Turco S.J. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 1998, 6:35-40.
15. Holm A., Tejle K., Magnusson K.E., Descoteaux A., Rasmusson B. Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: correlation with impaired translocation of PKCalpha and defective phagosome maturation. Cell. Microbiol. 2001, 3:439-447.
16. Lodge R., Diallo T.O., Descoteaux A. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell. Microbiol. 2006, 8:1922-1931.
17. Vinet A.F., Jananji S., Turco S.J., Fukuda M., Descoteaux A. Exclusion of synaptotagmin V at the phagocytic cup by Leishmania donovani lipophosphoglycan results in decreased promastigote internalization. Microbiology 2011, 157:2619-2628.
18. Ilg T. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J. 2000, 19:1953-1962.
19. Pimenta P.F., Saraiva E.M., Rowton E., Modi G.B., Garraway L.A., Beverley S.M., Turco S.J., Sacks D.L. Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9155-9159.
20. Sacks D.L., Pimenta P.F., McConville M.J., Schneider P., Turco S.J. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J. Exp. Med. 1995, 181:685-697.
21. Sacks D.L., Modi G., Rowton E., Spath G., Epstein L., Turco S.J., Beverley S.M. The role of phosphoglycans in Leishmania-sand fly interactions. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:406-411.
22. Blackwell J.M., Ezekowitz R.A., Roberts M.B., Channon J.Y., Sim R.B., Gordon S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 1985, 162:324-331.
23. Chawla M., Vishwakarma R.A. Alkylacylglycerolipid domain of gpi molecules of Leishmania is responsible for inhibition of PKC-mediated c-fos expression. J. Lipid Res. 2003, 44:594-600.
24. Yoneyama K.A., Tanaka A.K., Silveira T.G., Takahashi H.K., Straus A.H. Characterization of Leishmania (Viannia) braziliensis membrane microdomains, and their role in macrophage infectivity. J. Lipid Res. 2006, 47:2171-2178.
25. Assis R.R., Ibraim I.C., Noronha F.S., Turco S.J., Soares R.P. Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure. PLoS. Negl. Trop. Dis. 2012, 6:e1543.
26. Ilg T. Proteophosphoglycans of Leishmania. Parasitol. Today 2000, 16:489-497.
27. Rogers M.E., Ilg T., Nikolaev A.V., Ferguson M.A., Bates P.A. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 2004, 430:463-467.
28. Rogers M.E., Bates P.A. Leishmania manipulation of sand fly feeding behavior results in enhanced transmission. PLoS Pathog. 2007, 3:e91.
29. Rogers M., Kropf P., Choi B.S., Dillon R., Podinovskaia M., Bates P., Muller I. Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the l-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog. 2009, 5:e1000555.
30. Piani A., Ilg T., Elefanty A.G., Curtis J., Handman E. Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function. Microbes Infect. 1999, 1:589-599.
31. Kavoosi G., Ardestani S.K., Kariminia A., Zeinali M., Alimohammadian M.H. Leishmania major: effects of proteophosphoglycan on reactive oxygen species, IL-12, IFN-gamma and IL-10 production in healthy individuals. Exp. Parasitol. 2008, 120:62-66.
32. Mottram J.C., Coombs G.H., Alexander J. Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 2004, 7:375-381.
33. Alexander J., Coombs G.H., Mottram J.C. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 1998, 161:6794-6801.
34. Williams R.A., Tetley L., Mottram J.C., Coombs G.H. Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana. Mol. Microbiol. 2006, 61:655-674.
35. Cameron P., McGachy A., Anderson M., Paul A., Coombs G.H., Mottram J.C., Alexander J., Plevin R. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J. Immunol. 2004, 173:3297-3304.
36. Mottram J.C., Souza A.E., Hutchison J.E., Carter R., Frame M.J., Coombs G.H. Evidence from disruption of the lmCPB gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6008-6013.
37. Abu-Dayyeh I., Hassani K., Westra E.R., Mottram J.C., Olivier M. Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions. Infect. Immun. 2010, 78:2438-2445.
38. De Souza Leao S., Lang T., Prina E., Hellio R., Antoine J.C. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 1995, 108(Pt 10):3219-3231.
39. Sanderson S.J., Westrop G.D., Scharfstein J., Mottram J.C., Coombs G.H. Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens. FEBS Lett. 2003, 542:12-16.
40. Bryson K., Besteiro S., McGachy H.A., Coombs G.H., Mottram J.C., Alexander J. Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response. Infect. Immun. 2009, 77:2971-2978.
41. McCall L.I., Matlashewski G. Localization and induction of the a2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol. Microbiol. 2010, 77:518-530.
42. Remaley A.T., Glew R.H., Kuhns D.B., Basford R.E., Waggoner A.S., Ernst L.A., Pope M. Leishmania donovani: surface membrane acid phosphatase blocks neutrophil oxidative metabolite production. Exp. Parasitol. 1985, 60:331-341.
43. 2 production. J. Biol. Chem. 1984, 259:11173-11175.
44. Katakura K., Kobayashi A. Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes. Infect. Immun. 1988, 56:2856-2860.
45. Downing T., Imamura H., Decuypere S., Clark T.G., Coombs G.H., Cotton J.A., Hilley J.D., de Doncker S., Maes I., Mottram J.C., Quail M.A., Rijal S., Sanders M., Schonian G., Stark O., Sundar S., Vanaerschot M., Hertz-Fowler C., Dujardin J.C., Berriman M. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 2011, 21:2143-2156.
46. Bates P.A., Dwyer D.M. Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes. Mol. Biochem. Parasitol. 1987, 26:289-296.
47. Shakarian A.M., Joshi M.B., Yamage M., Ellis S.L., Debrabant A., Dwyer D.M. Members of a unique histidine acid phosphatase family are conserved amongst a group of primitive eukaryotic human pathogens. Mol. Cell. Biochem. 2003, 245:31-41.
48. Das S., Saha A.K., Remaley A.T., Glew R.H., Dowling J.N., Kajiyoshi M., Gottlieb M. Hydrolysis of phosphoproteins and inositol phosphates by cell surface phosphatase of Leishmania donovani. Mol. Biochem. Parasitol. 1986, 20:143-153.
49. Joshi M.B., Mallinson D.J., Dwyer D.M. The human pathogen Leishmania donovani secretes a histidine acid phosphatase activity that is resistant to proteolytic degradation. J. Eukaryot. Microbiol. 2004, 51:108-112.
50. Yao C., Donelson J.E., Wilson M.E. The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Mol. Biochem. Parasitol. 2003, 132:1-16.
51. Schneider P., Rosat J.P., Bouvier J., Louis J., Bordier C. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol. 1992, 75:196-206.
52. Pimenta P.F., Saraiva E.M., Sacks D.L. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp. Parasitol. 1991, 72:191-204.
53. Brittingham A., Morrison C.J., McMaster W.R., McGwire B.S., Chang K.P., Mosser D.M. Role of the Leishmania surface protease GP63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 1995, 155:3102-3111.
54. Mosser D.M., Edelson P.J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 1985, 135:2785-2789.
55. Brittingham A., Chen G., McGwire B.S., Chang K.P., Mosser D.M. Interaction of Leishmania GP63 with cellular receptors for fibronectin. Infect. Immun. 1999, 67:4477-4484.
56. McGwire B.S., Chang K.P., Engman D.M. Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease GP63. Infect. Immun. 2003, 71:1008-1010.
57. Seay M.B., Heard P.L., Chaudhuri G. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun. 1996, 64:5129-5137.
58. Chen D.Q., Kolli B.K., Yadava N., Lu H.G., Gilman-Sachs A., Peterson D.A., Chang K.P. Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of GP63 level in promastigotes and their infection of macrophages in vitro. Infect. Immun. 2000, 68:80-86.
59. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 1992, 71:713-716.
60. Corradin S., Mauel J., Ransijn A., Sturzinger C., Vergeres G. Down-regulation of MARCKS-related protein (MRP) in macrophages infected with Leishmania. J. Biol. Chem. 1999, 274:16782-16787.
61. Li J., Aderem A. Macmarcks, a novel member of the MARCKS family of protein kinase c substrates. Cell 1992, 70:791-801.
62. Corradin S., Ransijn A., Corradin G., Roggero M.A., Schmitz A.A., Schneider P., Mauel J., Vergeres G. MARCKS-related protein (MRP) is a substrate for the Leishmania major surface protease leishmanolysin (GP63). J. Biol. Chem. 1999, 274:25411-25418.
63. Blanchette J., Racette N., Faure R., Siminovitch K.A., Olivier M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IL-1-gamma-triggered JAK2 activation. Eur. J. Immunol. 1999, 29:3737-3744.
64. Gomez M.A., Contreras I., Halle M., Tremblay M.L., McMaster R.W., Olivier M. Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci. Signal. 2009, 2:ra58.
65. Abu-Dayyeh I., Shio M.T., Sato S., Akira S., Cousineau B., Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl. Trop. Dis. 2008, 2:e305.
66. Contreras I., Gomez M.A., Nguyen O., Shio M.T., McMaster R.W., Olivier M. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog. 2010, 6:e1001148.
67. Al-Mutairi M.S., Cadalbert L.C., McGachy H.A., Shweash M., Schroeder J., Kurnik M., Sloss C.M., Bryant C.E., Alexander J., Plevin R. Map kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 2010, 6:e1001192.
68. Kar S., Ukil A., Sharma G., Das P.K. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase c isoforms. J. Leukoc. Biol. 2010, 88:9-20.
69. Gregory D.J., Godbout M., Contreras I., Forget G., Olivier M. A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression. Eur. J. Immunol. 2008, 38:1071-1081.
70. Guizani-Tabbane L., Ben-Aissa K., Belghith M., Sassi A., Dellagi K. Leishmania major amastigotes induce p50/c-rel NF-kappaB transcription factor in human macrophages: involvement in cytokine synthesis. Infect. Immun. 2004, 72:2582-2589.
71. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997, 9:240-246.
72. Jaramillo M., Gomez M.A., Larsson O., Shio M.T., Topisirovic I., Contreras I., Luxenburg R., Rosenfeld A., Colina R., McMaster R.W., Olivier M., Costa-Mattioli M., Sonenberg N. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 2011, 9:331-341.
73. Silverman J.M., Clos J., de'Oliveira C.C., Shirvani O., Fang Y., Wang C., Foster L.J., Reiner N.E. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J. Cell Sci. 2010, 123:842-852.
74. Hassani K., Antoniak E., Jardim A., Olivier M. Temperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function. PLoS One 2011, 6:e18724.
75. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
76. Silverman J.M., Clos J., Horakova E., Wang A.Y., Wiesgigl M., Kelly I., Lynn M.A., McMaster W.R., Foster L.J., Levings M.K., Reiner N.E. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J. Immunol. 2010, 185:5011-5022.
77. Lieke T., Nylen S., Eidsmo L., McMaster W.R., Mohammadi A.M., Khamesipour A., Berg L., Akuffo H. Leishmania surface protein GP63 binds directly to human natural killer cells and inhibits proliferation. Clin. Exp. Immunol. 2008, 153:221-230.
78. Bogdan C., Donhauser N., Doring R., Rollinghoff M., Diefenbach A., Rittig M.G. Fibroblasts as host cells in latent leishmaniasis. J. Exp. Med. 2000, 191:2121-2130.
79. Halle M., Gomez M.A., Stuible M., Shimizu H., McMaster W.R., Olivier M., Tremblay M.L. The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J. Biol. Chem. 2009, 284:6893-6908.
80. Sorensen A.L., Hey A.S., Kharazmi A. Leishmania major surface protease GP63 interferes with the function of human monocytes and neutrophils in vitro. APMIS 1994, 102:265-271.
81. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
82. Guimaraes-Costa A.B., Nascimento M.T., Froment G.S., Soares R.P., Morgado F.N., Conceicao-Silva F., Saraiva E.M. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc. Natl. Acad. Sci. U.S.A. 2009, 6748-6753.
83. Gabriel C., McMaster W.R., Girard D., Descoteaux A. Leishmania donovani promastigotes evade the antimicrobial activity of neutrophil extracellular traps. J. Immunol. 2010, 185:4319-4327.